KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Restructuring Costs (2021 - 2025)

Historic Restructuring Costs for LifeMD (LFMD) over the last 4 years, with Q3 2025 value amounting to $6.7 million.

  • LifeMD's Restructuring Costs fell 745.24% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year increase of 8022.06%. This contributed to the annual value of $35.8 million for FY2024, which is 4553.29% up from last year.
  • Latest data reveals that LifeMD reported Restructuring Costs of $6.7 million as of Q3 2025, which was down 745.24% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Restructuring Costs registered a high of $15.8 million during Q4 2024, and its lowest value of $20896.0 during Q2 2021.
  • Moreover, its 4-year median value for Restructuring Costs was $7.7 million (2024), whereas its average is $7.2 million.
  • The largest annual percentage gain for LifeMD's Restructuring Costs in the last 5 years was 3200.25% (2025), contrasted with its biggest fall of 745.24% (2025).
  • Quarter analysis of 4 years shows LifeMD's Restructuring Costs stood at $20896.0 in 2021, then surged by 118.51% to $45659.0 in 2022, then surged by 34487.86% to $15.8 million in 2024, then crashed by 57.56% to $6.7 million in 2025.
  • Its Restructuring Costs was $6.7 million in Q3 2025, compared to $10.9 million in Q2 2025 and $8.5 million in Q1 2025.